IkappaB kinase inhibitors (Millennium)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameIkappaB kinase inhibitors (Millennium)
Drug Alias NameIKK2 inhibitors (Millennium)NFkappaB inhibitors (Millennium)MLN-120APS-1145MLN-120B +[7] 
ClassificationSmall molecules
Mechanisms of ActionInhibitor of nuclear factor kappa-B kinase subunit beta inhibitorsNuclear factor NF-kappa-B complex inhibitorsAnticancer protein kinase inhibitors
TargetsNuclear factor NF-kappa-B complexInhibitor of nuclear factor kappa-B kinase subunit beta
Therapy Area/IndicationsInflammationBrain InjuriesArthritis, Rheumatoid +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMillennium Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMillennium Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsInflammationBrain InjuriesArthritis, Rheumatoid +[4] 

Other Information

ATC CodeN/A
Related LinksN/A